Literature DB >> 11444825

Downregulation of p21/WAF1 expression by thymidylate synthase.

E K Kastanos1, M Zajac-Kaye, P A Dennis, C J Allegra.   

Abstract

We developed a cell system where expression of thymidylate synthase (TS), an enzyme essential for DNA synthesis, can be modulated by a Zn(2+)-inducible promoter in MCF-7 cells. We found that overexpression of TS resulted in downregulation of p21 protein and mRNA levels. Statistical analysis demonstrated a significant downregulation of p21, but not a statistically significant decrease in p53 protein levels following TS induction. Since p21 is known to be transcriptionally activated by p53, these results suggest that TS downregulation of p21 may be occurring through a p53-independent mechanism in this in vitro cell system. In addition, cell cycle analysis demonstrated that downregulation of p21 by TS resulted in a decreased G(1)/S ratio in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444825     DOI: 10.1006/bbrc.2001.5145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population.

Authors:  Wang-Hong Xu; Ji-Rong Long; Wei Zheng; Zhi-Xian Ruan; Qiuyin Cai; Jia-Rong Cheng; Gen-Ming Zhao; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

2.  Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance.

Authors:  Sanjay Popat; Richard Wort; Richard S Houlston
Journal:  BMC Cancer       Date:  2006-06-05       Impact factor: 4.430

3.  Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma.

Authors:  Takashi Shirasaki; Shin-ichiro Maruya; Hiroki Mizukami; Seiji Kakehata; Hidekachi Kurotaki; Soroku Yagihashi; Hideichi Shinkawa
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.